Additionally, Gonzalez-Ortiz et al. demonstrated that plasma brain-derived tau (BD-Tau) with p-tau alongside Aβ42/Aβ40 as a blood-based based-biomarker for diagnosis of AD. Here, MAPT is linked to Alzheimer disease.